Aprameya Engineering Ltd
Incorporated in September 2003, Aprameya Engineering Limited specializes in installing and maintaining Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centers.[1]
- Market Cap ₹ 296 Cr.
- Current Price ₹ 156
- High / Low ₹ 360 / 140
- Stock P/E 58.1
- Book Value ₹ 36.4
- Dividend Yield 0.00 %
- ROCE 12.8 %
- ROE 7.63 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Stock is trading at 4.27 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 368 days.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of Nifty SME Emerge
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 135.71 | 55.13 | |
| 111.31 | 44.60 | |
| Operating Profit | 24.40 | 10.53 |
| OPM % | 17.98% | 19.10% |
| 0.59 | 0.49 | |
| Interest | 3.18 | 3.64 |
| Depreciation | 0.09 | 0.09 |
| Profit before tax | 21.72 | 7.29 |
| Tax % | 25.78% | 29.63% |
| 16.12 | 5.13 | |
| EPS in Rs | 8.47 | 2.68 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -59% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -68% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 8% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 19.04 | 19.04 |
| Reserves | 45.22 | 50.36 |
| 30.34 | 7.13 | |
| 49.36 | 5.74 | |
| Total Liabilities | 143.96 | 82.27 |
| 1.38 | 1.39 | |
| CWIP | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 |
| 142.58 | 80.88 | |
| Total Assets | 143.96 | 82.27 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| -10.64 | 31.23 | |
| -0.41 | -4.45 | |
| 10.89 | -26.66 | |
| Net Cash Flow | -0.16 | 0.12 |
| Free Cash Flow | -10.89 | 30.27 |
| CFO/OP | -28% | 355% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 320.38 | 367.58 |
| Inventory Days | 26.78 | 32.14 |
| Days Payable | 150.18 | 37.75 |
| Cash Conversion Cycle | 196.97 | 361.97 |
| Working Capital Days | 165.60 | 376.78 |
| ROCE % | 12.76% |
Insights
In beta| Mar 2024 | Mar 2025 | |
|---|---|---|
| Number of Employees Numbers ・Standalone data |
|
|
| Number of States Present Numbers |
||
| Revenue Mix - Medical Equipment Solutions % |
||
| Revenue Mix - Turnkey Projects % |
||
| Number of Critical Care Beds Installed Numbers |
||
| Number of Dialysis Centers Delivered (Rajasthan) Numbers |
||
| Number of Global OEM Partnerships Numbers |
||
| Order Book Rs Mn |
||
Extracted by Screener AI
Documents
Announcements
-
Press Release
10 June 2026 - Aprameya Medtech signs exclusive sales and marketing alliance with SonoScape India across South and West India.
-
Agreements
10 June 2026 - Subsidiary signed exclusive marketing agreement with Sonoscape for MIS products in western and southern India until 31 March 2027.
-
General Updates
28 May 2026 - Aprameya Medtech appoints Jalan Alkesh & Associates as secretarial auditor on 27 May 2026 for five years.
-
Outcome of Board Meeting
28 May 2026 - Board approved audited FY26 results, auditor reports, related party transactions, and AGM scrutiniser appointment.
-
Press Release
28 May 2026 - FY26 press release: collections normalized, ₹100 crore receivables recovered, bids worth ₹190 crore submitted, subsidiary facility planned.
Annual reports
Concalls
-
Nov 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT REC
Business Segments
A) Healthcare Infrastructure Projects[1][2]
The company offers turnkey solutions for developing healthcare facilities, covering everything from design to execution of ICUs, NICUs, PICUs, Modular Operation Theatres (MOTs), Dialysis Centers, and Prefabricated Wards. The scope also includes integration of MEP systems, fire safety, structural design, and hospital interiors. These projects are tailored for public healthcare institutions, focused on customized infrastructure delivery.